ArticleCurrent cardiovascular risk reports2015

State-of-the-Art: Hypo-responsiveness to oral antiplatelet therapy in patients with type 2 diabetes mellitus.

Dharam J Kumbhani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.